Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Value, Access and Regulatory Strategy Workshop
Session 2: Adaptive Pathways and Innovative Medicines Development for Improved Access
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PhD
- Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
- AstraZeneca , France
Speaker(s)
Adaptive Pathways: An HTA Perspective
Jacoline Bouvy, PhD
- Scientific Adviser, Science Policy and Research Programme
- National Institute for Health and Care Excellence (NICE), United Kingdom
Adaptive Pathways: An Industry’s Perspective
Claudine Sapède, PharmD
- Director, Global HTA Policy
- Novartis Pharma AG, Switzerland
Richard Barker, PhD
- Founding Director
- Centre for the Advancement of Sustainable Medical Innovation (CASMI), United Kingdom
Adaptive Pathways: A Clinician's Perspective
Rosa Giuliani, MD
- Consultant in Medical Oncology, S. Camillo-Forlanini Hospital, Italy
- European Society for Medical Oncology (ESMO), Switzerland